Indexed on: 20 May '19Published on: 19 May '19Published in: Contraception
To evaluate outcomes with mifepristone 200mg orally followed 24-48h later by misoprostol 800 mcg vaginally for medical abortion at 64-70days of gestation. We reviewed electronic databases and medical records for medical abortion cases at 64-70days' gestation at British Pregnancy Advisory Service clinics in England and Wales from May 2015 through October 2016. Women selected in-office follow-up or self-evaluation of abortion outcome using a checklist along with low sensitivity urine pregnancy testing. We excluded cases in which we could not locate records and when women did not proceed with medical abortion, did not use misoprostol following mifepristone if abortion had not occurred, and did not attend a scheduled follow-up assessment. We analyzed demographic characteristics, treatment outcomes, and significant adverse events. We defined treatment success as complete abortion without surgical evacuation and without continuing pregnancy. Of 2743 cases identified, we could not locate 40 charts and excluded 30 cases, leaving a final sample of 2673. Overall, 2538 (94.9%, 95% CI 94.1-95.8) women had a successful medical abortion. Reasons for failure included continuing pregnancy (n=90, 3.4%, 95% CI 2.7-4.1), retained non-viable pregnancy (n=2, 0.1%, 95% CI 0-0.2), and incomplete abortion (n=43, 1.6%, 95% CI 1.1-2.1). Of those with continuing pregnancies, 81 underwent a uterine aspiration and 9 opted to continue the pregnancy. Thirty-five (1.3%, 95% CI 0.9-1.7) women had significant adverse events, 16 (0.6%, 95% CI 0.3-0.9) underwent an in-hospital aspiration. Pelvic infection (n=4, 0.2%) and transfusion (n=1, 0.03%) occurred rarely. Medical abortion from 64-70days with mifepristone and vaginal misoprostol is effective with a low rate of serious adverse events. Medical abortion between 64 and 70days of gestation may be offered on an outpatient basis using mifepristone and vaginal misoprostol. Service provision without an in-person follow-up is feasible. Not all women with a continuing pregnancy after medical abortion treatment opt to have an aspiration procedure. Copyright © 2019. Published by Elsevier Inc.